Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.
Reads0
Chats0
TLDR
It is found that loss of D USP2 induces angiogenesis, while forced expression of DUSP2 inhibits microvessel formation in xenografted mouse tumours, and suggests that blocking hypoxia–DUSp2–IL‐8 signalling may be a plausible approach for therapeutic intervention in cancer.Abstract:
Dual-specificity phosphatase 2 (DUSP2) is a negative regulator of mitogen-activated protein kinases. Our previous study showed that DUSP2 expression is down-regulated in many human cancers and loss of DUSP2 promotes cancer progression; however, the underlying mechanism remains largely uncharacterized. Herein, we found that loss of DUSP2 induces angiogenesis, while forced expression of DUSP2 inhibits microvessel formation in xenografted mouse tumours. Genome-wide screening of expression profiles, and meta-analysis of clinical data, identified that the level of interleukin-8 (IL-8) correlated negatively with that of DUSP2, suggesting that it may be a downstream target of DUSP2. Molecular characterization revealed that DUSP2 inversely regulates IL-8 expression, mediated by ERK1/2 and C/EBPα-dependent transcriptional regulation. Further study showed that hypoxia-induced IL-8 expression in cancer cells is also mediated via down-regulation of DUSP2. Treatment with the IL-8 receptor inhibitor reparixin or knockdown of IL-8 in cancer cells abolished angiogenesis induced by loss of DUSP2. Functionally, knockdown of DUSP2 enhanced tumour growth and metastasis, which were abolished by treatment with reparixin or knockdown of IL-8 in an orthotopic mouse model. Taken together, our results demonstrate that hypoxia inhibits DUSP2 expression in colon cancer, leading to up-regulation of IL-8, which facilitates angiogenesis and tumour metastasis. Our findings suggest that blocking hypoxia-DUSP2-IL-8 signalling may be a plausible approach for therapeutic intervention in cancer. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.read more
Citations
More filters
Journal ArticleDOI
Role of Matrix Metalloproteinases in Angiogenesis and Cancer.
Saray Quintero-Fabián,Rodrigo Arreola,Enrique Becerril-Villanueva,Julio César Torres-Romero,Victor Arana-Argáez,Julio Lara-Riegos,Mario Alberto Ramírez-Camacho,María Elizbeth Alvarez-Sánchez +7 more
TL;DR: This review analyzes recent knowledge on MMPs and their participation in angiogenesis through the modulation of the balance between pro- and anti-angiogenic factors and concludes that Matrix metalloproteinases participate in the disruption, tumor neovascularization, and subsequent metastasis.
Journal ArticleDOI
Pathophysiological implications of hypoxia in human diseases
Pai Sheng Chen,Wen Tai Chiu,Pei Ling Hsu,Shih Chieh Lin,I-Chen Peng,Chia Yih Wang,Shaw Jenq Tsai +6 more
TL;DR: This review article will summarize current understandings regarding the molecular mechanism of hypoxia in these common and important diseases including cancer, myocardial ischemia, metabolic diseases, and chronic heart and kidney diseases and in reproductive diseases such as preeclampsia and endometriosis.
Journal ArticleDOI
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
Jan Korbecki,Klaudyna Kojder,Patrycja Kapczuk,Patrycja Kupnicka,Barbara Gawrońska-Szklarz,Izabela Gutowska,Dariusz Chlubek,Irena Baranowska-Bosiacka +7 more
TL;DR: In this paper, the effect of hypoxia-induced changes on CXC chemokine expression on the angiogenesis, lymphangiogenesis and recruitment of various cells to the tumor niche, including myeloid-derived suppressor cells (MDSCs), tumorassociated macrophages (TAMs), tumor-associated neutrophils (TANs), regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs).
Journal ArticleDOI
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
TL;DR: This review summarizes the most recent findings on the role of CXC chemokines and their receptors in CRC and discusses their possible value as prognostic or predictive biomarkers as well as the possibility of targeting them as a therapeutic strategy.
Journal ArticleDOI
The Role of Interleukins in Colorectal Cancer.
TL;DR: This work comprehensively reviewed the oncogenic or antitumour function of each interleukin involved in CRC pathogenesis and progression by elucidating the underlying mechanisms and further driven the profound prospect ofinterleukins in the treatment of colorectal cancer.
References
More filters
Journal ArticleDOI
Angiogenesis in cancer and other diseases
Peter Carmeliet,Rakesh K. Jain +1 more
TL;DR: Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases and integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases, but owing to several unanswered questions, caution is needed.
Journal ArticleDOI
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
Jo A. Forsythe,Bing-Hua Jiang,Narayan V. Iyer,Faton Agani,Sandra W. Leung,Robert D. Koos,Gregg L. Semenza +6 more
TL;DR: HIF-1 is implicate in the activation of VEGF transcription in hypoxic cells and this work demonstrates the involvement of Hif-1 in theactivation of V EGF transcription.
Journal ArticleDOI
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes,Elizabeth Allen,James Hudock,Takaaki Takeda,Hiroaki Okuyama,Francesc Viñals,Masahiro Inoue,Gabriele Bergers,Douglas Hanahan,Oriol Casanovas +9 more
TL;DR: It is reported that angiogenesis inhibitors targeting the VEGF pathway demonstrate antitumor effects in mouse models of pancreatic neuroendocrine carcinoma and glioblastoma but concomitantly elicit tumor adaptation and progression to stages of greater malignancy, with heightened invasiveness and in some cases increased lymphatic and distant metastasis.
Journal ArticleDOI
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
TL;DR: In this paper, the authors summarize lessons learned from preclinical and clinical studies over the past decade and propose strategies for improving antiangiogenic therapy outcomes for malignant and nonmalignant diseases.
Journal ArticleDOI
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies
TL;DR: In population-based cohorts, UC increases the risk of CRC 2.4-fold, and male sex, young age at diagnosis with UC, and extensive colitis increase the risk.